Treeline Biosciences

company

About

Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.

Details

Last Funding Type
Series A
Last Funding Money Raised
$261.26M
Industries
Biotechnology,Health Care,Life Science,Medical
Founded date
Jan 1, 2021
Number Of Employee
101 - 250
Operating Status
Active
Legal Name
Treeline Biosciences, Inc.

Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.

The company was founded in 2021 and is headquartered in Stamford, Connecticut.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$473.26M
Treeline Biosciences has raised a total of $473.26M in funding over 2 rounds. Their latest funding was raised on Oct 11, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 11, 2022 Series A $261.26M 5 Kohlberg Kravis Roberts Detail
Apr 27, 2021 Series A $212M 6 ARCH Venture Partners
GV
OrbiMed
Detail

Investors

Number of Lead Investors
Number of Investors
4
8
Treeline Biosciences is funded by 8 investors. Kohlberg Kravis Roberts and GV are the most recent investors.
Investor Name Lead Investor Funding Round
Kohlberg Kravis Roberts Yes Series A
GV Yes Series A
Access Industries Series A
ARCH Venture Partners Series A
OrbiMed Series A
Rock Springs Capital Series A
Ajax Health Series A
Casdin Capital Series A

Employee Profiles

Number of Employee Profiles
3
Treeline Biosciences has 3 current employee profiles, including Executive Josh Bilenker
Executive
Executive
Executive